These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23809366)

  • 1. Beyond amyloid: getting real about nonamyloid targets in Alzheimer's disease.
    Herrup K; Carrillo MC; Schenk D; Cacace A; Desanti S; Fremeau R; Bhat R; Glicksman M; May P; Swerdlow R; Van Eldik LJ; Bain LJ; Budd S
    Alzheimers Dement; 2013 Jul; 9(4):452-458.e1. PubMed ID: 23809366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the amyloid hypothesis of Alzheimer's disease therapeutically relevant?
    Teich AF; Arancio O
    Biochem J; 2012 Sep; 446(2):165-77. PubMed ID: 22891628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acyl-coenzyme A:cholesterol acyltransferase 1 blockage enhances autophagy in the neurons of triple transgenic Alzheimer's disease mouse and reduces human P301L-tau content at the presymptomatic stage.
    Shibuya Y; Niu Z; Bryleva EY; Harris BT; Murphy SR; Kheirollah A; Bowen ZD; Chang CCY; Chang TY
    Neurobiol Aging; 2015 Jul; 36(7):2248-2259. PubMed ID: 25930235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer's Disease.
    Uddin MS; Kabir MT; Niaz K; Jeandet P; Clément C; Mathew B; Rauf A; Rengasamy KRR; Sobarzo-Sánchez E; Ashraf GM; Aleya L
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32168835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenylbutyric acid reduces amyloid plaques and rescues cognitive behavior in AD transgenic mice.
    Wiley JC; Pettan-Brewer C; Ladiges WC
    Aging Cell; 2011 Jun; 10(3):418-28. PubMed ID: 21272191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward an early diagnosis and treatment of Alzheimer's disease.
    Nordberg A
    Int Psychogeriatr; 2003 Sep; 15(3):223-37. PubMed ID: 14756159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are N- and C-terminally truncated Aβ species key pathological triggers in Alzheimer's disease?
    Dunys J; Valverde A; Checler F
    J Biol Chem; 2018 Oct; 293(40):15419-15428. PubMed ID: 30143530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Amyloid-beta accumulation cycle" as a prevention and/or therapy target for Alzheimer's disease.
    Rao CV; Asch AS; Carr DJJ; Yamada HY
    Aging Cell; 2020 Mar; 19(3):e13109. PubMed ID: 31981470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease model.
    Imamura T; Yanagihara YT; Ohyagi Y; Nakamura N; Iinuma KM; Yamasaki R; Asai H; Maeda M; Murakami K; Irie K; Kira JI
    Neurobiol Dis; 2020 Apr; 137():104739. PubMed ID: 31927145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combination of aricept with a traditional Chinese medicine formula, smart soup, may be a novel way to treat Alzheimer's disease.
    Wang Y; Wang Y; Sui Y; Yu H; Shen X; Chen S; Pei G; Zhao J; Ding J
    J Alzheimers Dis; 2015; 45(4):1185-95. PubMed ID: 25690664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-Clinical Neuroprotective Evidences and Plausible Mechanisms of Sulforaphane in Alzheimer's Disease.
    Kim J
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metal Ions in Alzheimer's Disease: A Key Role or Not?
    Liu Y; Nguyen M; Robert A; Meunier B
    Acc Chem Res; 2019 Jul; 52(7):2026-2035. PubMed ID: 31274278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AMPK: Potential Therapeutic Target for Alzheimer's Disease.
    Yang L; Jiang Y; Shi L; Zhong D; Li Y; Li J; Jin R
    Curr Protein Pept Sci; 2020; 21(1):66-77. PubMed ID: 31424367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connective tissue growth factor (CTGF) expression in the brain is a downstream effector of insulin resistance- associated promotion of Alzheimer's disease beta-amyloid neuropathology.
    Zhao Z; Ho L; Wang J; Qin W; Festa ED; Mobbs C; Hof P; Rocher A; Masur S; Haroutunian V; Pasinetti GM
    FASEB J; 2005 Dec; 19(14):2081-2. PubMed ID: 16186174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperspectral imaging signatures detect amyloidopathy in Alzheimer's mouse retina well before onset of cognitive decline.
    More SS; Vince R
    ACS Chem Neurosci; 2015 Feb; 6(2):306-15. PubMed ID: 25354367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A small molecule transcription factor EB activator ameliorates beta-amyloid precursor protein and Tau pathology in Alzheimer's disease models.
    Song JX; Malampati S; Zeng Y; Durairajan SSK; Yang CB; Tong BC; Iyaswamy A; Shang WB; Sreenivasmurthy SG; Zhu Z; Cheung KH; Lu JH; Tang C; Xu N; Li M
    Aging Cell; 2020 Feb; 19(2):e13069. PubMed ID: 31858697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of diet- and genetically-induced brain insulin resistance on amyloid pathology in a mouse model of Alzheimer's disease.
    Wakabayashi T; Yamaguchi K; Matsui K; Sano T; Kubota T; Hashimoto T; Mano A; Yamada K; Matsuo Y; Kubota N; Kadowaki T; Iwatsubo T
    Mol Neurodegener; 2019 Apr; 14(1):15. PubMed ID: 30975165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of FRM-36143 as a new γ-secretase modulator for the potential treatment of familial Alzheimer's disease.
    Blain JF; Bursavich MG; Freeman EA; Hrdlicka LA; Hodgdon HE; Chen T; Costa DE; Harrison BA; Kapadnis S; Murphy DA; Nolan S; Tu Z; Tang C; Burnett DA; Patzke H; Koenig G
    Alzheimers Res Ther; 2016 Aug; 8(1):34. PubMed ID: 27572246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacology of novel anti-Alzheimer disease modifying medications.
    Caraci F; Bosco P; Leggio GM; Malaguarnera M; Drago F; Bucolo C; Salomone S
    Curr Top Med Chem; 2013; 13(15):1853-63. PubMed ID: 23931438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.